Solesence Inc

Aktienanalyse zu Solesence Inc (SLSN)

$0.867

-0.045 (-5.16%)Zum Schluss

Loading chart…
Hoch
0.885
Eröffnung
0.881
Volumengewichteter Durchschnittskurs
0.87
Volumen
25.11K
Marktkap.
—
Tief
0.855
Umsatz
21.82K
EV/EBITDA, TTM
0.00

Solesence, Inc., formerly Nanophase Technologies Corporation, provides healthcare solutions across beauty and life science categories. It is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The Company partners with global and indie brands, leveraging its proprietary Active Stress Defense technology suite (Original Active Stress Defense, Kleair, and Bloom) to bring environmental protection beauty products to market via over a dozen market-ready offerings that embrace self-expression, health care, and self-care across skin care and color cosmetic categories. It also offers custom development, with turnkey options available across all paths to market. The Company’s products are formulated using its own mineral sunscreen actives, which are produced in its Chicagoland facility where it has been producing sunscreen actives, including the zinc oxide sunscreen active.

ir.solesence.com

KI-Analyse of Solesence Inc (SLSN)

Kaufen

Solesence, Inc. appears to be a good buy right now due to its recent price momentum and improving gross margins. The current price is $0.86, with a recent 5-day change of +11.14%, indicating positive short-term performance. Additionally, the gross margin has improved to 30.97% in Q2 2026, up from 28.87% in Q2 2025, reflecting better cost management. However, the main risk is the company's significant year-to-date decline of -42.93%, which highlights volatility and potential challenges ahead.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Solesence Inc (SLSN) beträgt 11.36, verglichen mit dem 5-Jahres-Durchschnitt von 6.54.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
6.54
Aktuelles P/E
11.36
Überbewertet
12.97
Unterbewertet
0.11

Erwartetes EV/EBITDA

Stark unterbewertet
5J-Durchschnitt EV/EBITDA
0.00
Aktuelles EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes KUV

Stark unterbewertet
5J-Durchschnitt P/S
0.00
Aktuelles P/S
0.00
Überbewertet
0.00
Unterbewertet
0.00

Alphio-AI-Kursszenarien für SLSN

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%SLSN

$4.63

Szenariopreis

B

Basis

Basis · 50%SLSN

$4.55

Szenariopreis

B

Bärisch

Bärisch · 25%SLSN

$3.96

Szenariopreis

Event-Zeitleiste

2026-08-19 (ET)

17:30:00

Solesence Focuses on Operational Execution and Financial Discipline

2026-02-26 (ET)

08:20:00

Solesence Appoints Yoolie Park as VP of Brand Partnerships

2025-11-11 (ET)

07:01:26

Solesence announces Q3 earnings per share of 2 cents, down from 4 cents a year ago.

2025-11-10 (ET)

08:26:47

Solesence names Yoana Dvorzsak as Vice President of Innovation and Product Integrity

2025-09-03 (ET)

08:09:27

Solesence names Kevin Cureton as its new president and CEO.

News

SLSN FAQ – beantwortet von Alphio AI

Solesence, Inc., formerly Nanophase Technologies Corporation, provides healthcare solutions across beauty and life science categories. It is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The Company partners with global and indie brands, leveraging its proprietary Active Stress Defense technology suite (Original Active Stress Defense, Kleair, and Bloom) to bring environmental protection beauty products to market via over a dozen market-ready offerings that embrace self-expression, health care, and self-care across skin care and color cosmetic categories. It also offers custom development, with turnkey options available across all paths to market. The Company’s products are formulated using its own mineral sunscreen actives, which are produced in its Chicagoland facility where it has been producing sunscreen actives, including the zinc oxide sunscreen active. It operates in the Consumer Non-Cyclicals sector.

Solesence, Inc. appears to be a good buy right now due to its recent price momentum and improving gross margins. The current price is $0.86, with a recent 5-day change of +11.14%, indicating positive short-term performance. Additionally, the gross margin has improved to 30.97% in Q2 2026, up from 28.87% in Q2 2025, reflecting better cost management. However, the main risk is the company's significant year-to-date decline of -42.93%, which highlights volatility and potential challenges ahead.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln